Merzbach, S.; Hoffman, A.; Lazarovici, P.; Gilon, C.; Amer, R.
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis. Pharmaceutics 2024, 16, 723.
https://doi.org/10.3390/pharmaceutics16060723
AMA Style
Merzbach S, Hoffman A, Lazarovici P, Gilon C, Amer R.
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis. Pharmaceutics. 2024; 16(6):723.
https://doi.org/10.3390/pharmaceutics16060723
Chicago/Turabian Style
Merzbach, Shira, Amnon Hoffman, Philip Lazarovici, Chaim Gilon, and Radgonde Amer.
2024. "Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis" Pharmaceutics 16, no. 6: 723.
https://doi.org/10.3390/pharmaceutics16060723
APA Style
Merzbach, S., Hoffman, A., Lazarovici, P., Gilon, C., & Amer, R.
(2024). Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis. Pharmaceutics, 16(6), 723.
https://doi.org/10.3390/pharmaceutics16060723